Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Importance of GOLD Guidelines for Chronic Obstructive Pulmonary Disease.

Sadlonova J, Osinova D, Rozborilova E, Osina O, Novakova E, Sadlonova V.

Adv Exp Med Biol. 2017 Jun 25. doi: 10.1007/5584_2017_44. [Epub ahead of print]

PMID:
28647926
2.

Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.

Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators.

N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15.

3.

Deregulation of energetic metabolism in the clear cell renal cell carcinoma: A multiple pathway analysis based on microarray profiling.

Soltysova A, Breza J, Takacova M, Feruszova J, Hudecova S, Novotna B, Rozborilova E, Pastorekova S, Kadasi L, Krizanova O.

Int J Oncol. 2015 Jul;47(1):287-95. doi: 10.3892/ijo.2015.3014. Epub 2015 May 19.

PMID:
25998032
4.

European screening for alpha1 -antitrypsin deficiency in subjects with lung disease.

Greulich T, Averyanov A, Borsa L, Rozborilová E, Vaicius D, Major T, Chopyak V, Tudorache V, Konstantinova T, Camprubí S.

Clin Respir J. 2017 Jan;11(1):90-97. doi: 10.1111/crj.12310. Epub 2015 Jun 11.

PMID:
25919395
5.

[Occupational tuberculosis in Slovakia and in the Czech Republic].

Buchancová J, Svihrová V, Legáth L, Bátora I, Záborský T, Rozborilová E, Fenclová Z, Urban P, Zibolenová J, Osina O, Janoušek M, Hudečková H.

Epidemiol Mikrobiol Imunol. 2014 Sep;63(3):200-5. Czech.

PMID:
25412484
6.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

7.

Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD.

Watz H, Mistry SJ, Lazaar AL; IPC101939 investigators.

Pulm Pharmacol Ther. 2013 Oct;26(5):588-95. doi: 10.1016/j.pupt.2013.05.004. Epub 2013 May 21.

PMID:
23701917
8.

The impact of hypertonic saline inhalation on mucociliary clearance and nasal nitric oxide.

Bencova A, Vidan J, Rozborilova E, Kocan I.

J Physiol Pharmacol. 2012 Jun;63(3):309-13.

9.

Bidirectional link between upper and lower airways in patients with allergic rhinitis.

Bencova A, Rozborilova E, Antosova M.

Eur J Med Res. 2009 Dec 7;14 Suppl 4:18-20.

10.

Exhaled nitric oxide - circadian variations in healthy subjects.

Antosova M, Bencova A, Psenkova A, Herle D, Rozborilova E.

Eur J Med Res. 2009 Dec 7;14 Suppl 4:6-8.

11.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

12.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
13.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

14.

The effectiveness for prevention of tuberculosis in patients with inflammatory rheumatic diseases treated with TNF inhibitors.

Rybar I, Rozborilova E, Zanova E, Micekova D, Solovic I, Rovensky J.

Bratisl Lek Listy. 2008;109(4):164-7.

PMID:
18814432
15.

Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.

Mokry M, Joppa P, Slaba E, Zidzik J, Habalova V, Kluchova Z, Micietova L, Rozborilova E, Salagovic J, Tkacova R.

Med Sci Monit. 2008 Aug;14(8):CR392-8.

PMID:
18667995
16.

Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.

Stasko J, Galajda P, Ivanková J, Hollý P, Rozborilová E, Kubisz P.

Clin Appl Thromb Hemost. 2007 Oct;13(4):410-5.

PMID:
17911193
17.

[Potential predictors of therapeutic response in patients with cryptogenic fibrosing alveolitis].

Vysehradský R, Rozborilová E, Straková J, Polácek H, Hut'ka Z.

Vnitr Lek. 2002 Mar;48(3):185-91. Slovak.

PMID:
11968578
18.

[Pharmacotherapy of chronic obstructive pulmonary disease in patients with indications for long-term home oxygen therapy].

Rozborilová E, Vysehradský R, Strapko P, Krivcíková K.

Vnitr Lek. 2002 Mar;48(3):182-4. Slovak.

PMID:
11968577
19.

[Levels of alpha 1-antitrypsin in the blood of patients with chronic bronchitis].

Hal'ák O, Pullmann R, Jamriska P, Rozborilová E, Chalupová E, Kavcová E, Hazlingerová M.

Bratisl Lek Listy. 1989 Apr;90(4):290-3. Slovak.

PMID:
2788479
20.

[Obstacles in the effective therapy of tuberculosis with antitubercular agents].

Hal'ák O, Rozborilová E, Chalupová E, Sebová T.

Bratisl Lek Listy. 1984 Jun;81(6):684-7. Slovak. No abstract available.

PMID:
6467061

Supplemental Content

Loading ...
Support Center